← Scroll for more →
Astrazeneca PLC (AZN)
Pharmaceutical Preparations
Latest Price
$161.47
TTM P/E
--
Normalized P/E
38.35
Div Yield
--
Book Value
31.40
P/B Ratio
5.14
Valuation metrics
adjust assumptions →EPS: $6.54
Target P/E: 38×
Formula: EPS × P/E
P/E Fair Value
$248.52
+54% upside
Institutional Ownership
0.1% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Mediolanum International Funds Ltd | 487.4K | $92.0M | 0.03% | -- | 2026-06-30 |
| Fayez Sarofim & Co | 179.6K | $34.0M | 0.01% | -4.08M | 2026-06-30 |
| Mengis Capital Management, Inc. | 46.7K | $8.0M | 0.00% | +38 | 2026-06-30 |
| Wahed Invest LLC | 44.3K | $8.0M | 0.00% | +9.1K | 2026-06-30 |
| Stanley-Laman Group, Ltd. | 23.6K | $4.0M | 0.00% | -457 | 2026-06-30 |
| Westport Asset Management Inc | 7.5K | $1.0M | 0.00% | -- | 2026-06-30 |
| Raelipskie Partnership | 7.4K | $1.0M | 0.00% | -- | 2026-06-30 |
| A. D. Beadell Investment Counsel, Inc. | 7.0K | $1.0M | 0.00% | -- | 2026-06-30 |
| 1620 Investment Advisors, Inc. | 5.1K | -- | 0.00% | +29 | 2026-06-30 |
| Cullinan Associates Inc | 4.0K | -- | 0.00% | -- | 2026-06-30 |